Company intelligence / Profile preview

CSR Pharma Group

Bridgewater, New Jersey, United Statescsrpharmsvcs.com ↗

Ownership: Private
Development stage: Other

Overview

CSR Pharma Group has received multiple grants from the New Jersey Economic Development Authority for biological drug manufacturing and R&D innovation. It has executed an exclusive global licensing agreement with Harvard University for novel cancer epitope technology targeting advanced/metastatic disease. The company collaborates with Rutgers University on preclinical studies of its genome-associated precision therapy platform in GBM using mouse models. It is progressing toward additional discovery technologies and pivotal preclinical/IND-enabling work. No clinical results have been reported publicly as of June 2025.

Therapeutic areas: Oncology
Modalities: Biological drug (biologic)Protein engineering
Industry: Biotech

Drug pipeline

1 asset

GAPTX

Preclinical

Partnerships

Rutgers University – collaboration on pilot study funded by NJEDA CSIT grant.Harvard University – exclusive global licensing agreement for novel cancer epitope technology.Johnson & Johnson JLABS Incubator – formed biotech startup unit at this incubator hub in 2019.

Beyond the preview

Go deeper on CSR Pharma Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CSR Pharma Group.

Explore the full profile